Guangxi Wuzhou Zhongheng Group Co., Ltd (SHA:600252)
2.570
+0.010 (0.39%)
Jun 6, 2025, 3:00 PM CST
SHA:600252 Revenue
Guangxi Wuzhou Zhongheng Group had revenue of 742.03M CNY in the quarter ending March 31, 2025, a decrease of -7.92%. This brings the company's revenue in the last twelve months to 2.21B, down -31.73% year-over-year. In the year 2024, Guangxi Wuzhou Zhongheng Group had annual revenue of 2.27B, down -26.67%.
Revenue (ttm)
2.21B
Revenue Growth
-31.73%
P/S Ratio
3.86
Revenue / Employee
742.83K
Employees
2,971
Market Cap
8.52B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 2.27B | -825.72M | -26.67% |
Dec 31, 2023 | 3.10B | 382.77M | 14.10% |
Dec 31, 2022 | 2.71B | -448.07M | -14.17% |
Dec 31, 2021 | 3.16B | -514.55M | -14.00% |
Dec 31, 2020 | 3.68B | -137.66M | -3.61% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 29.19B |
Shenzhen Mindray Bio-Medical Electronics | 35.59B |
WuXi AppTec | 39.59B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
Sichuan Biokin Pharmaceutical | 5.82B |
Aier Eye Hospital Group | 21.81B |
Shanghai United Imaging Healthcare | 10.43B |
Yunnan Baiyao Group Co.,Ltd | 40.10B |